SPY312.18+4.10 1.33%
DIA263.17+5.32 2.06%
IXIC9,682.91+74.54 0.78%

UBS Maintains Neutral on Insulet, Raises Price Target to $213

UBS maintains Insulet (NASDAQ:PODD) with a Neutral and raises the price target from $195 to $213.

Benzinga · 05/08/2020 17:32

UBS maintains Insulet (NASDAQ:PODD) with a Neutral and raises the price target from $195 to $213.